The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
Open accessAbstract
OBJECTIVE: Because curcumin's anti-inflammatory properties may protect the brain from neurodegeneration, we studied its effect on memory in non-demented adults and explored its impact on brain amyloid and tau accumulation using 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile positron emission tomography (FDDNP-PET). METHODS: Forty subjects (age 51-84 years) were randomized to a bioavailable form of curcumin (Theracurmin® containing 90 mg of curcumin twice daily [N = 21]) or placebo (N = 19) for 18 months. Primary outcomes were verbal (Buschke Selective Reminding Test [SRT]) and visual (Brief Visual Memory Test-Revised [BVMT-R]) memory, and attention (Trail Making A) was a secondary outcome. FDDNP-PET signals (15 curcumin, 15 placebo) were determined in amygdala, hypothalamus, medial and lateral temporal, posterior cingulate, parietal, frontal, and motor (reference) regions. Mixed effects general linear models controlling for age and education, and effect sizes (ES; Cohen's d) were estimated. RESULTS: SRT Consistent Long-Term Retrieval improved with curcumin (ES = 0.63, p = 0.002) but not with placebo (ES = 0.06, p = 0.8; between-group: ES = 0.68, p = 0.05). Curcumin also improved SRT Total (ES = 0.53, p = 0.002), visual memory (BVMT-R Recall: ES = 0.50, p = 0.01; BVMT-R Delay: ES = 0.51, p = 0.006), and attention (ES = 0.96, p < 0.0001) compared with placebo (ES = 0.28, p = 0.1; between-group: ES = 0.67, p = 0.04). FDDNP binding decreased significantly in the amygdala with curcumin (ES = -0.41, p = 0.04) compared with placebo (ES = 0.08, p = 0.6; between-group: ES = 0.48, p = 0.07). In the hypothalamus, FDDNP binding did not change with curcumin (ES = -0.30, p = 0.2), but increased with placebo (ES = 0.26, p = 0.05; between-group: ES = 0.55, p = 0.02). CONCLUSIONS: Daily oral Theracurmin may lead to improved memory and attention in non-demented adults. The FDDNP-PET findings suggest that symptom benefits are associated with decreases in amyloid and tau accumulation in brain regions modulating mood and memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Shytle, R. D., Tan, J., Bickford, P. C., Rezai-Zadeh, K. P., Hou, L., Zeng, J., Sanberg, P. R., Sanberg, C. D., Alberte, R. S., Fink, R. C., et al. (2012) · Current Alzheimer Research · doi:10.2174/156720512800492459 · Cited by 66
RetractedWang, P., Su, C., Li, R., Wang, H., Ren, Y., Sun, H., Yang, J., Sun, J., Shi, J., Tian, J., et al. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23322 · Cited by 65
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Co-planar stereotaxic atlas of the human brain
Laitinen, L. (1989) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(89)90128-5 · Cited by 7,565
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
The Neuropsychological Assessment
Ogden, J. A. (2005) · Fractured Minds · doi:10.1093/oso/9780195171358.003.0002 · Cited by 4,364
Doody, R. S., Stevens, J. C., Beck, C., Dubinsky, R. M., Kaye, J. A., Gwyther, L., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,720
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Self-citationHaapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.1.2 · Cited by 1,057
Selective reminding for analysis of memory and learning
Buschke, H. (1973) · Journal of Verbal Learning and Verbal Behavior · doi:10.1016/s0022-5371(73)80034-9 · Cited by 1,056
Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample
Rossetti, H. C., Lacritz, L. H., Cullum, C. M., & Weiner, M. F. (2011) · Neurology · doi:10.1212/wnl.0b013e318230208a · Cited by 801
Shoghi-Jadid, K., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S.-C., et al. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 770
Self-citationPET of Brain Amyloid and Tau in Mild Cognitive Impairment
Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., Lavretsky, H., Burggren, A. C., Cole, G. M., Vinters, H. V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054625 · Cited by 738
Self-citationBenedict, R. H. B., Schretlen, D. J., Groninger, L. D., Dobraski, M., & Shpritz, B. (1996) · Psychological Assessment · doi:10.1037//1040-3590.8.2.145 · Cited by 723
Baum, L., Lam, C. W. K., Cheung, S. K.-K., Kwok, T., Lui, V., Tsoh, J., Lam, L., Leung, V., Hui, E., Ng, C., et al. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160862c · Cited by 592
Diagnostic and Statistical Manual of Mental Disorders: The Solution or the Problem?
Reiff, M. I., & Feldman, H. M. (2014) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000017 · Cited by 562
Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., Gylys, K. H., Badmaev, V., Heath, D. D., Apostolova, L. G., et al. (2012) · Alzheimer's Research & Therapy · doi:10.1186/alzrt146 · Cited by 541
What cognitive abilities are involved in trail-making performance?
Salthouse, T. A. (2011) · Intelligence · doi:10.1016/j.intell.2011.03.001 · Cited by 512
Baum, L., & Ng, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6403 · Cited by 483
The Memory Functioning Questionnaire for assessment of memory complaints in adulthood and old age.
Gilewski, M. J., Zelinski, E. M., & Schaie, K. W. (1990) · Psychology and Aging · doi:10.1037/0882-7974.5.4.482 · Cited by 464
Innovative Preparation of Curcumin for Improved Oral Bioavailability
Sasaki, H., Sunagawa, Y., Takahashi, K., Imaizumi, A., Fukuda, H., Hashimoto, T., Wada, H., Katanasaka, Y., Kakeya, H., Fujita, M., et al. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.660 · Cited by 450
Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
Curry Consumption and Cognitive Function in the Elderly
Ng, T.-P., Chiam, P.-C., Lee, T., Chua, H.-C., Lim, L., & Kua, E.-H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj267 · Cited by 353
Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation
Cuomo, J., Appendino, G., Dern, A. S., Schneider, E., McKinnon, T. P., Brown, M. J., Togni, S., & Dixon, B. M. (2011) · Journal of Natural Products · doi:10.1021/np1007262 · Cited by 339
Soni, K. B., & Kuttan, R. (1992) · PubMed · Cited by 278
Gota, V. S., Maru, G. B., Soni, T. G., Gandhi, T. R., Kochar, N., & Agarwal, M. G. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9024807 · Cited by 274
The significance of neuroinflammation in understanding Alzheimer’s disease
Eikelenboom, P., Veerhuis, R., Scheper, W., Rozemuller, A. J. M., van Gool, W. A., & Hoozemans, J. J. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0575-6 · Cited by 262
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 262
Kanai, M., Imaizumi, A., Otsuka, Y., Sasaki, H., Hashiguchi, M., Tsujiko, K., Matsumoto, S., Ishiguro, H., & Chiba, T. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1673-1 · Cited by 258
Education delays accelerated decline on a memory test in persons who develop dementia
Hall, C. B., Derby, C., LeValley, A., Katz, M. J., Verghese, J., & Lipton, R. B. (2007) · Neurology · doi:10.1212/01.wnl.0000278163.82636.30 · Cited by 257
Goozee, K. G., Shah, T. M., Sohrabi, H. R., Rainey-Smith, S. R., Brown, B., Verdile, G., & Martins, R. N. (2016) · British Journal of Nutrition · doi:10.1017/s0007114515004687 · Cited by 244
Rainey-Smith, S. R., Brown, B. M., Sohrabi, H. R., Shah, T., Goozee, K. G., Gupta, V. B., & Martins, R. N. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516001203 · Cited by 224
Towards a Pharmacophore for Amyloid
Landau, M., Sawaya, M. R., Faull, K. F., Laganowsky, A., Jiang, L., Sievers, S. A., Liu, J., Barrio, J. R., & Eisenberg, D. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001080 · Cited by 210
Self-citationEfficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial
Sanmukhani, J., Satodiya, V., Trivedi, J., Patel, T., Tiwari, D., Panchal, B., Goel, A., & Tripathi, C. B. (2014) · Phytotherapy Research · doi:10.1002/ptr.5025 · Cited by 207
Ryu, E. K., Choe, Y. S., Lee, K.-H., Choi, Y., & Kim, B.-T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0607193 · Cited by 198
Sperling, R. A., Aisen, P. S. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J. A., Montine, T. J., et al. (2011) · Cited by 197
Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer's disease patients
Zhang, L., Fiala, M., Cashman, J., Sayre, J., Espinosa, A., Mahanian, M., Zaghi, J., Badmaev, V., Graves, M. C., Bernard, G., et al. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10101 · Cited by 181
Prevalence of dementia in an urban population in Kerala, India
Shaji, S., Bose, S., & Verghese, A. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.2.136 · Cited by 180
Clinical development of curcumin in neurodegenerative disease
Hu, S., Maiti, P., Ma, Q., Zuo, X., Jones, M. R., Cole, G. M., & Frautschy, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1044981 · Cited by 179
Lopresti, A. L., & Drummond, P. D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.047 · Cited by 174
Agdeppa, E. D., Kepe, V, Petri, A., Satyamurthy, N., Liu, J., Huang, S.-C., Small, G. W., Cole, G. M., & Barrio, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00907-7 · Cited by 172
Self-citationCurcumin induces changes in expression of genes involved in cholesterol homeostasis
Peschel, D., Koerting, R., & Naß, N. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.03.007 · Cited by 156
Hypothalamic pathology in Alzheimer's disease
Saper, C. B., & German, D. C. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90325-9 · Cited by 149
Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?
Mazzanti, G., & Giacomo, S. D. (2016) · Molecules · doi:10.3390/molecules21091243 · Cited by 143
Polyphenols in dementia: From molecular basis to clinical trials
Molino, S., Dossena, M., Buonocore, D., Ferrari, F., Venturini, L., Ricevuti, G., & Verri, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.07.021 · Cited by 119
Lavretsky, H., Siddarth, P., Kepe, V., Ercoli, L. M., Miller, K. J., Burggren, A. C., Bookheimer, S. Y., Huang, S., Barrio, J. R., & Small, G. W. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181953b82 · Cited by 118
Self-citationPredictors of cognitive change in middle-aged and older adults with memory loss
Small, G. W., Rue, A. L., Komo, S., Kaplan, A. R., & Mandelkern, M. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1757 · Cited by 116
Self-citationCurcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression
Feng, D., Ohlsson, L., & Duan, R. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-40 · Cited by 108
Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle
Sun, M. H., Gao, Y., Guo, C., Cao, F., Song, Z., Xi, Y., Yu, A., Li, A., & Zhai, G. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-9907-4 · Cited by 92
Protein Binding in Patients With Late-Life Depression
Kumar, A., Kepe, V., Barrio, J. R., Siddarth, P., Manoukian, V., Elderkin‐Thompson, V., & Small, G. W. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.122 · Cited by 90
Self-citationPrediction of Cognitive Decline by Positron Emission Tomography of Brain Amyloid and Tau
Small, G. W., Siddarth, P., Kepe, V., Ercoli, L. M., Burggren, A. C., Bookheimer, S. Y., Miller, K. J., Kim, J., Lavretsky, H., Huang, S.-C., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.559 · Cited by 84
Self-citationCurcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth.
Ambegaokar, S. S., Wu, L. D., Alamshahi, K., Lau, J., Jazayeri, L., Chan, S. L., Khanna, P., Hsieh, E. M., & Timiras, P. S. (2003) · PubMed · Cited by 72
Liu, J., Kepe, V., Žabjek, A., Petrič, A., Padgett, H. C., Satyamurthy, N., & Barrio, J. R. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0061-4 · Cited by 72
Self-citationSmall, G. W., Siddarth, P., Burggren, A. C., Kepe, V., Ercoli, L. M., Miller, K. J., Lavretsky, H., Thompson, P. M., Cole, G. M., Huang, S. C., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.516 · Cited by 65
Self-citationCurcumin Labeling of Neuronal Fibrillar Tau Inclusions in Human Brain Samples
Mohorko, N., Repovš, G., Popović, M., Kovács, G. G., & Bresjanac, M. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181d709eb · Cited by 60
L-deprenyl in Alzheimer's disease: Cognitive and behavioral effects
Freedman, M., Rewilak, D., Xerri, T., Cohen, S., Gordon, A. S., Shandling, M. R., & Logan, A. G. (1998) · Neurology · doi:10.1212/wnl.50.3.660 · Cited by 60
Curcumin as a putative antidepressant
Seo, H., Wang, S., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1008457 · Cited by 42
da Costa, P., Gonçalves, J. F., Baldissarelli, J., Mann, T. R., Abdalla, F. H., Fiorenza, A. M., da Rosa, M. M., Carvalho, F. B., Gutierres, J. M., de Andrade, C. M., et al. (2015) · Environmental Toxicology · doi:10.1002/tox.22213 · Cited by 41
Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region
Wong, K. P., Wardak, M., Shao, W., Dahlbom, M. L., Kepe, V., Liu, J., Satyamurthy, N., Small, G. W., Barrio, J. R., & Huang, S. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1293-8 · Cited by 37
Self-citationAmyloid binding properties of curcumin analogues in Alzheimer’s disease postmortem brain tissue
Veldman, E. R., Jia, Z., Halldin, C., & Svedberg, M. M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.045 · Cited by 28
Neuropsychological Tests for Predicting Cognitive Decline in Older Adults
Baerresen, K., Miller, K. J., Hanson, E. R., Miller, J. S., Dye, R. V., Hartman, R. E., Vermeersch, D. A., & Small, G. W. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.7 · Cited by 20
Self-citationPrice (1999) · doi:10.1002/1531-8249(199903)45:3
(2009) · PubMed
Cited by
Peng, Y., Ao, M., Dong, B., Jiang, Y., Yu, L., Chen, Z., Hu, C., & Xu, R. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s327378 · Cited by 827
The therapeutic potential of curcumin: A review of clinical trials
Salehi, B., Stojanović-Radić, Z., Matejić, J., Sharifi-Rad, M., Anil Kumar, N. V., Martins, N., & Sharifi-Rad, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.016 · Cited by 495
Long, H.-Z., Cheng, Y., Zhou, Z.-W., Luo, H.-Y., Wen, D.-D., & Gao, L.-C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648636 · Cited by 489
Tau-targeting therapies for Alzheimer disease: Current status and future directions
Congdon, E. E., Ji, C., Tetlow, A. M., Jiang, Y., & Sigurdsson, E. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00883-2 · Cited by 371
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Hegde, M., Girisa, S., BharathwajChetty, B., Vishwa, R., & Kunnumakkara, A. B. (2023) · ACS Omega · doi:10.1021/acsomega.2c07326 · Cited by 301
Metadata
- Authors
- Small, G. W., Siddarth, P., Li, Z., Miller, K. J., Ercoli, L., Emerson, N. D., Martinez, J., Wong, K.-P., Liu, J., Merrill, D. A., Chen, S. T., Henning, S. M., Satyamurthy, N., Huang, S.-C., Heber, D., & Barrio, J. R.
- Venue
- The American Journal of Geriatric Psychiatry
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 26
- Issue
- 3
- Pages
- 266-277
- ISSN
- 1064-7481 (ISSN-L)
- OpenAlex
- W2766602779
- Cited by
- 350
- References
- 70
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.